跳至主要内容
临床试验/CTRI/2013/10/004092
CTRI/2013/10/004092招募中2 期

A Multi centric, Single Blind, Randomized, parallel group study to compare efficacy and safety of coded unani formulation UNIM 221 with Metformin in patients with Ziabetus Sukkari Qism e Sani (Diabetes Mellitus Type II)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 624 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
624

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex in the age group of 18-65 years.
  • 2. Fasting plasma glucose levels between 126 and 150 mg/dl
  • 3. 2hr plasma glucose levels between 200 and 250 mg/dl
  • (2 hours after ingestion of 75 gm of glucose in 300 ml of water)
  • 4. HbA1c level >=6.5%
  • 5. Presence of any of the following symptoms and signs of diabetes
  • Utash mufrit (Polydipsia)
  • Kasrat al-Bawl (Polyuria)
  • Kasrat al-Ishtiha (Polyphagia)
  • Bawl Layli (Nocturia)
  • Iâ??ya (Fatigue)
  • Naqs al-Wazn (Loss of Weight)
  • Burning sensation in palm and soles
  • Sadr (Giddiness)
  • Naqs al-Shahwa (Loss of Libido)

排除标准

  • Subjects with fasting plasma glucose level 150 mg/dl and /or PP
  • plasma glucose level 250 mg/dl
  • Subjects on Insulin therapy
  • Diabetes Mellitus-Type I
  • Secondary Diabetes Mellitus
  • Diabetes Mellitus associated with complications of Ketoacidosis
  • Patients on systemic corticosteroids/ disease modifying agents
  • Ischemic Heart Disease/ Hypertension/ Hyperlipidemia
  • Liver disorders SGPT 105 IU/L
  • Impaired Renal function tests
  • Anemia Hb 8 gm/dl in Males and Hb 6 gm/dl in females
  • Obese Subjects â?? BMI 30
  • Pregnant and lactating women
  • Drug addicts/ Alcoholics
  • Malignancy/ Epilepsy
  • Any infective disorder requiring long-term treatment
  • Patient on any other treatment including use of alternative

研究者

发起方
Central Council for Research in Unani Medicine CCRUM New Delhi

相似试验